NM_001302084.2:c.-30+5T>C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001302084.2(TOP6BL):​c.-30+5T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0099 in 1,254,476 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.0073 ( 8 hom., cov: 30)
Exomes 𝑓: 0.010 ( 70 hom. )

Consequence

TOP6BL
NM_001302084.2 splice_region, intron

Scores

2
Splicing: ADA: 0.003980
2

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.360

Publications

0 publications found
Variant links:
Genes affected
TOP6BL (HGNC:26197): (TOP6B like initiator of meiotic double strand breaks) Predicted to be involved in meiotic DNA double-strand break formation and reciprocal meiotic recombination. Predicted to be located in chromosome. Implicated in gestational trophoblastic neoplasm. [provided by Alliance of Genome Resources, Apr 2022]
SPTBN2 (HGNC:11276): (spectrin beta, non-erythrocytic 2) Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
SPTBN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 5
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal recessive spinocerebellar ataxia 14
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 11-66744924-T-C is Benign according to our data. Variant chr11-66744924-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 3055893.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0103 (11303/1102516) while in subpopulation SAS AF = 0.0211 (462/21874). AF 95% confidence interval is 0.0195. There are 70 homozygotes in GnomAdExome4. There are 5414 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001302084.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TOP6BL
NM_001302084.2
MANE Select
c.-30+5T>C
splice_region intron
N/ANP_001289013.1Q8N6T0-6
TOP6BL
NM_024650.4
c.30+5T>C
splice_region intron
N/ANP_078926.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TOP6BL
ENST00000540737.7
TSL:2 MANE Select
c.-30+5T>C
splice_region intron
N/AENSP00000444319.1Q8N6T0-6
TOP6BL
ENST00000901167.1
c.-307T>C
5_prime_UTR
Exon 1 of 17ENSP00000571226.1
TOP6BL
ENST00000901168.1
c.-126T>C
5_prime_UTR
Exon 1 of 15ENSP00000571227.1

Frequencies

GnomAD3 genomes
AF:
0.00732
AC:
1112
AN:
151842
Hom.:
8
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00181
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00295
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.0166
Gnomad FIN
AF:
0.0187
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00995
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.0135
AC:
262
AN:
19442
AF XY:
0.0140
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00323
Gnomad ASJ exome
AF:
0.0161
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0184
Gnomad NFE exome
AF:
0.00991
Gnomad OTH exome
AF:
0.00719
GnomAD4 exome
AF:
0.0103
AC:
11303
AN:
1102516
Hom.:
70
Cov.:
33
AF XY:
0.0104
AC XY:
5414
AN XY:
522804
show subpopulations
African (AFR)
AF:
0.00113
AC:
26
AN:
23010
American (AMR)
AF:
0.00460
AC:
39
AN:
8472
Ashkenazi Jewish (ASJ)
AF:
0.00716
AC:
103
AN:
14382
East Asian (EAS)
AF:
0.0000753
AC:
2
AN:
26572
South Asian (SAS)
AF:
0.0211
AC:
462
AN:
21874
European-Finnish (FIN)
AF:
0.0204
AC:
718
AN:
35270
Middle Eastern (MID)
AF:
0.00833
AC:
38
AN:
4562
European-Non Finnish (NFE)
AF:
0.0103
AC:
9562
AN:
924316
Other (OTH)
AF:
0.00801
AC:
353
AN:
44058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
606
1212
1819
2425
3031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00733
AC:
1114
AN:
151960
Hom.:
8
Cov.:
30
AF XY:
0.00778
AC XY:
578
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.00181
AC:
75
AN:
41464
American (AMR)
AF:
0.00295
AC:
45
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5150
South Asian (SAS)
AF:
0.0170
AC:
82
AN:
4824
European-Finnish (FIN)
AF:
0.0187
AC:
197
AN:
10546
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00995
AC:
676
AN:
67932
Other (OTH)
AF:
0.00380
AC:
8
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00835
Hom.:
3
Bravo
AF:
0.00600

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
TOP6BL-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
16
DANN
Benign
0.79
PhyloP100
0.36
PromoterAI
0.10
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0040
dbscSNV1_RF
Benign
0.088
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs574408551; hg19: chr11-66512395; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.